Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Using bioactive injectable resin composite in anterior class v carious lesions can provide better aesthetic outcome and marginal integrity by releasing multiple ions, including fluoride. This offers better marginal integrity due to presence of S-PRG fillers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2025
CompletedFirst Posted
Study publicly available on registry
April 30, 2025
CompletedStudy Start
First participant enrolled
June 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2026
CompletedJune 18, 2025
June 1, 2025
10 months
April 12, 2025
June 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Marginal discoloration using FDI criteria
12 Month
Study Arms (2)
Beautifil flow plus x f00
ACTIVE COMPARATORBioactive giomer based injectable resin composite
G-aenial universal injectable resin composite
ACTIVE COMPARATORconventional injectable resin composite
Interventions
Giomers utilize surface pre-reacted glass (SPRG) technology, which involves an acid-base reaction between fluorine-containing glass particles and polymer-containing acid when exposed to water. This reaction results in the formation of a glass ionomer phase, which is then dispersed throughout the resin. Furthermore, the S-PRG fillers present in giomer materials enable the continuous release and replenishment of fluoride, offering long-lasting protection against the recurrence of caries
Conventional injectable resin composite
Eligibility Criteria
You may qualify if:
- Age 20-60 years.
- Co-operative participants approving to participate in the study.
- Male or female patients.
- Medically free participants.
- Moderate or high caries risk participants.
You may not qualify if:
- Systemic disease or severe medical complications.
- Participants with a history of allergy to any component of restorations will be used in the study.
- Lack of compliance
- Evidence of severe bruxism, clenching, or temporomandibular joint disorders or bizarre habits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 12, 2025
First Posted
April 30, 2025
Study Start
June 10, 2025
Primary Completion
April 13, 2026
Study Completion
April 13, 2026
Last Updated
June 18, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share